share_log

HC Wainwright & Co. Maintains Buy on Blue Water Biotech, Raises Price Target to $9

Benzinga ·  Apr 26, 2023 10:37

HC Wainwright & Co. analyst Vernon Bernardino maintains Blue Water Biotech (NASDAQ:BWV) with a Buy and raises the price target from $7 to $9.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment